Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU
The Impact of Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU: Intervention Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Contact:
- Ashley Thompson, BSN, RN, IBCLC
- Phone Number: 507-422-5523
- Email: NICULactationStu@mayo.edu
-
Contact:
- Tawney DeBoth, BSN, RN, IBCLC
- Phone Number: 507-422-5523
- Email: NICULactationStu@mayo.edu
-
Principal Investigator:
- Ashley Elizabeth Thompson, BSN, RN, IBCLC
-
Sub-Investigator:
- Tawney DeBoth, BSN, RN, IBCLC
-
Sub-Investigator:
- Senna Hesbyn, BSN, RN, IBCLC
-
Sub-Investigator:
- Melissa Kurke, BSN, RN, IBCLC
-
Sub-Investigator:
- Alecia Robin, BSN, RN, IBCLC
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Maternal age > 20 years of age
- Read, write and understand English
- Infant NICU admit
- Infant birthplace of Rochester, MN (Mayo Clinic)
- Maternal adherence to pumping ≥ 8 times in 24 hours
- Mother enrolled within 72 hours of birth
- Gestational age of neonate at birth of < 34 0/7 weeks
Exclusion Criteria:
- Maternal extensive existing mindfulness practice
- Maternal breast/chest surgery
- Maternal polycystic ovarian syndrome (PCOS)
- Maternal current illicit substance abuse
- Diagnosis of maternal current severe mental health concerns
- Maternal multiple gestation (twins or higher order) pregnancy and delivery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Standard of Care
Mothers in the standard of care arm will undergo a standard lactation admission visit
|
No additional session with the lactation consultant will be provided beyond the standard of care lactation admission visit with a lactation consultant within 72 hours of their infant's admission to the NICU. On days 0, 10 and 20, participants will be asked to record pumping session times and breastmilk volumes expressed for 24 hours, collect salivary oxytocin sample and salivary cortisol sample at minute 4 of one pumping session, and fill out the GAD7, PSS, and PHQ-8 surveys. |
|
Experimental: Mindfulness-Based
Mothers in the mindfulness-based arm will receive mindfulness-based lactation education along with a standard lactation admission visit
|
In addition to the standard of care lactation admission visit, participants will receive an additional session with the lactation consultant for mindfulness-based lactation education. Participants will also be provided with a pumping meditation audio recording that they will be asked to listen to at least once daily for the next 20 days. On days 0, 10 and 20, participants will be asked to record pumping session times and breastmilk volumes expressed for 24 hours, collect salivary oxytocin sample and salivary cortisol sample at minute 4 of one pumping session, and fill out the GAD7, PSS, and PHQ-8 surveys. In addition, the intervention group participants will also be asked to record the number of times they listened to the recording daily, minutes listened to recording daily, and time of day listened to recording. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in breastmilk volume
Time Frame: Baseline, 10 days, 20 days
|
Volume will be reported in milliliters (mL)
|
Baseline, 10 days, 20 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in salivary oxytocin
Time Frame: Baseline, 10 days, 20 days
|
Baseline, 10 days, 20 days
|
|
Change in salivary cortisol
Time Frame: Baseline, 10 days, 20 days
|
Baseline, 10 days, 20 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ashley Thompson, Mayo Clinic
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 24-013742
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.